Applications Open for ABRC Investigator Grants

Posted on Sun/1/SeptemberSun/1/September by AZBio

The Arizona Biomedical Research Centre (ABRC) of the Arizona Department of Health Services is soliciting grant proposals for RFGA2024-022 Arizona Investigator Grant (AZ IG) or New Investigator Awards (NIA).

This is a two-phased application process. Approximately $10,5000,000 is available for biomedical grant projects over a period of three (3) years.

Continue reading→

C-Path Announces FDA Commissioner Robert Califf to Participate in Opening Session at Inaugural Global Impact Conference

Posted on Fri/30/AugustFri/30/August by Roxan Olivas

#CGIC24 Registration Nears Capacity; Closes Saturday, Aug. 31Continue reading→

Multi-year, 1143-patient genetic study identifies unique types of multiple myeloma

Posted on Sat/24/AugustThu/29/August by AZBio

TGen-led group confirms high-risk subgroup among cancer patientsContinue reading→

C-Path Awarded $1.5 Million Grant from Ara Parseghian Medical Research Fund at Notre Dame to Enhance Collaboration in Niemann-Pick Disease Research and Drug Development

Posted on Thu/22/AugustThu/22/August by Roxan Olivas

TUCSON, Ariz., August 22, 2024 — Critical Path Institute (C-Path) is thrilled to announce its Critical Path for Lysosomal Diseases (CPLD) Consortium has been awarded a grant from the Ara Parseghian Medical Research Fund (APMRF) at the University of Notre Dame.Continue reading→

C-Path’s TRxA Announces $250,000 Grant for Drug Development Project in Prostate Cancer

Posted on Thu/22/AugustThu/22/August by Roxan Olivas

TUCSON, Ariz., August 22, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award to Peter Wipf, Ph.D., a distinguished researcher and professor at the University of Pittsburgh, Department of ChemistryContinue reading→

Calviri Named Arizona Bioscience Company of the Year

Posted on Tue/20/AugustSat/24/August by AZBio

Calviri, a Phoenix, Arizona based company with a mission to end cancer worldwide and to accomplish this mission with affordable products, has been named the Arizona Bioscience Company of the Year and will be celebrated at the 20th annual AZBio Awards on September 18, 2024 at the Phoenix Convention Center.

Calviri was formed in 2017 to end cancer. The team was convinced this could be done as they had discovered a previously unappreciated, yet fundamental, molecular characteristic of all tumors that distinguishes them from healthy host cells. Calviri also invented chip technologies that would leverage their discovery to uniquely battle cancer. After years of research and many patents, Calviri is now developing multi-cancer tests to accurately detect stage 1 disease, which can be treated with its early-stage therapeutic vaccines. Calviri’s research has also shown them the path to the seeming impossible: a preventative cancer vaccine. All rooted in the power of Calviri’s molecular discoveries and semiconductor inventions, the company is now ready to globally provide diagnostics and vaccines that will end cancer. Full stop.

Continue reading→

New Short Term Shared Lab Space Available from CEI LabForce in Phoenix

Posted on Tue/20/AugustTue/20/August by AZBio

Thanks to generous support from the Flinn Foundation and the Arizona Department of Health Services, CEI LabForce is able to offer temporary shared lab space at their facility at 850 PBC in downtown Phoenix. Designed to support the needs of life science innovators at the proof-of-concept stage, the lab provides access to cutting-edge equipment and resources, enabling researchers and startups to accelerate their projects without the burden of substantial upfront investments.Continue reading→

Three Arizona Life Science Companies Move into the Fast Lane

Posted on Sat/17/AugustSat/17/August by AZBio

Each year the Arizona Bioindustry Association, Inc. shines a spotlight on three Arizona life science companies that have achieved outstanding milestones in the past 18 months. In 2024, Nectero Medical, Inc., PriZm Therapeutics, and The Patient Company are being honored with AZBio Fast Lane Awards on September 18, 2024 at the 20th annual AZBio Awards. Continue reading→

Mixed Perspectives on the 2 year anniversary of the Inflation Reduction Act

Posted on Fri/16/AugustFri/16/August by AZBio

August 16, 2024, marks the 2 year anniversary of the Inflation Reduction Act (IRA). One of the most talked about and written about policies of the current administration, The IRA has far reaching impacts. Whether they are positive or negative is a matter of perspective.Continue reading→

Exploring Pathways to Bioscience and Healthcare Careers during AZBW 2024

Posted on Thu/15/AugustThu/15/August by AZBio

Attention Teachers! Are you looking for free, engaging, on-demand resources to inspire your students with the possibilities in Arizona’s Bioscience and Healthcare industries? Thanks to the Exploring Pathways to Bioscience and Healthcare Careers grant, and support by the Flinn Foundation and the Office of the Maricopa County School Superintendent we have new resources for you and your students to enjoy during and after Arizona Bioscience Week.Continue reading→